PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 244.00
0.00 (0.00%)
Sep 2, 2026, 11:52 AM WIB
IDX:DGNS Market Cap
IDX:DGNS has a market cap or net worth of 335.5 billion as of September 1, 2026. Its market cap has increased by 83.84% in one year.
Market Cap
335.50B
Enterprise Value
390.36B
Revenue
176.49B
Ranking
n/a
PE Ratio
157.21
Stock Price
244.00
ChartMarket Cap Chart
Since January 15, 2021, IDX:DGNS's market cap has decreased from 337.50B to 335.50B, a decrease of -0.59%. That is a compound annual growth rate of -0.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 335.50B | 45.87% |
| Dec 30, 2025 | 230.00B | -5.64% |
| Dec 30, 2024 | 243.75B | -20.73% |
| Dec 29, 2023 | 307.50B | 0.82% |
| Dec 30, 2022 | 305.00B | -67.25% |
| Dec 30, 2021 | 931.25B | 175.93% |
| Jan 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 176.24T |
| PT Kalbe Farma Tbk. | 36.20T |
| PT Siloam International Hospitals Tbk | 27.79T |
| PT Mitra Keluarga Karyasehat Tbk | 25.84T |
| PT Maja Agung Latexindo Tbk | 506.75B |
| PT Royal Prima Tbk | 405.40B |
| PT Indofarma Tbk | 390.51B |
| PT Ikapharmindo Putramas Tbk | 325.14B |